Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction
- PMID: 12781360
- DOI: 10.1016/s1535-6108(03)00113-2
Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction
Abstract
Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources